Dynamic MR imaging for functional vascularization depends on tissue factor signaling in glioblastoma.
Cancer Biol Ther. 2018 Jan 15;:0
Authors: Chen X, Xie T, Fang J, Xue W, Kang H, Tong H, Guo Y, Zhang B, Wang S, Yang Y, Zhang W
Abstract
Glomeruloid vascular proliferation (GVP) is a diagnostic hallmark and links to aggressive behavior, therapy resistance and poor prognosis in glioblastoma (GBM). It lacks clinical approaches to predict and monitor its formation and dynamic change. Yet the mechanism of GVPs also remains largely unknown. Using an in situ GBM xenograft mouse model, combined clinical MRI images of pre-surgery tumor and pathological investigation, we demonstrated that the inhibition of tissue factor (TF) decreased GVPs in Mouse GBM xenograft model. TF shRNA reduced microvascular area and diameter, other than bevacizumab. TF dominantly functions via PAR2/HB-EGF-dependent activation under hypoxia in endothelial cells (ECs), resulting in a reduction of GVPs and cancer cells invasion. TF expression strongly correlated to GVPs and microvascular area (MVA) in GBM specimens from 56 patients, which could be quantitatively evaluated in an advanced MRI images system in 33 GBM patients. This study presented an approach to assess GVPs that could be served as a MRI imaging biomarker in GBM and uncovered a molecular mechanism of GVPs.
PMID: 29333924 [PubMed - as supplied by publisher]
http://ift.tt/2D5zLAv
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου